Pharma/BioTech Update: Bayer and Dimension Team Up For New Gene Therapy
Big news coming out of the pharma industry today. Earlier today, Dimension Therapeutics announced a $252 million licensing deal with…
Posts by tag: Pharmaceuticals
Man with Hemophilia Advocates For His Life
An interesting story developed over the weekend regarding a young man’s hemophilia factor medication and the integrated managed care system…
Pradaxa Settlement Announced
Boehringer Ingelheim has agreed to a settlement with 4,000 United States cases against their drug anticoagulant Pradaxa (dabigatran). This “comprehensive settlement”…
Pharma/Biotech Update: Advate Most Prescribed Recombinant Factor
According to a press release via The Wall Street Journal, Baxter International, Inc. announced that their recombinant factor VIII (8)…
Bayer HealthCare Announces Award Winners
Today, Bayer HealthCare announced that they had awarded more than 2 million in funding to 14 recipients residing in five…
Pharma/Biotech Update: NovoEight Provides Reduced Bleeding
Pharmaceutical company Novo Nordisk recently announced data from it’s phase 3 study on its upcoming recombinant coagulation factor VIII (8)…
Pharma/Biotech Update: Baxter Reveals Trial Results for vWD Drug
For those suffering from von Willebrand Disease (vWD) a new pharmaceutical option may be available to you at the beginning…
Pharma/BioTech Update: Biogen Idec’s Hemophilia Drug Price to Remain on Par
An article released today by FiercePharma stated that Biogen Idec’s new hemophilia B drug, Alprolix, will be priced similarly to older and…
New Jersey – Community College Raising Money for Hemophilia
Raritan Valley Community College recently sent out a press release announcing their third annual Hemophilia Bleeding Disorders Awareness Walk on…
Pharma/Biotech Update: Eloctate Meets Objectives in Hemophilia A Study
A recent article written by Michael Calia at NASDAQ shows promise for Biogen Idec’s up and coming hemophilia A (factor VIII deficiency)…